Misplaced Pages

Foravirumab is a monoclonal antibody for the prophylaxis of rabies. It is under development by Sanofi/Crucell.

References

1. International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
2. Khardori NM (2011). Biologic Response Modifiers in Infectious Diseases, An Issue of Infectious Disease Clinics. London: Elsevier Health Sciences. p. 158. ISBN 978-1-4557-1207-6.

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Drugs not assigned an ATC code
• Experimental monoclonal antibodies
• Antiinfective agent stubs
• Monoclonal antibody stubs